Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points

MeSH terms

• Bisphosphonate-Associated Osteonecrosis of the Jaw* / epidemiology
• Bisphosphonate-Associated Osteonecrosis of the Jaw* / etiology
• Bone Neoplasms* / secondary
• Humans
• Incidence
• Multiple Myeloma* / complications
• Multiple Myeloma* / drug therapy
• Osteonecrosis* / chemically induced
• Prognosis
• Retrospective Studies
• Zoledronic Acid